期刊文献+

一种新型抗纤维化小肽AcSDKP的构建及活性初步研究

A Novel AcSDKP Peptide with Anti-Fibrosis Activities In Vivo
下载PDF
导出
摘要 目的:以D型氨基酸替代的方式构建一种能抵抗血管紧张素转化酶(ACE)降解的异构体小肽AcSDKP,并对其抗纤维化活性进行初步研究,以期为AcSDKP在抗纤维化方面的应用提供依据。方法:用HPLC法检测D型氨基酸替代方式构建的AcSDKP异构体抗ACE降解的能力;用MTT法检测AcSDKP异构体对小鼠成纤维细胞L929和原代培养的心脏成纤维细胞增殖的影响;用流式细胞术检测AcSDKP异构体对骨髓干细胞(BMSC)向巨噬细胞分化的影响。结果:AcSDKP异构体均能抗ACE降解,能抑制L929细胞和心脏成纤维细胞增殖,能抑制BMSC向巨噬细胞分化。结论:构建了能抵抗ACE降解,在体外能抑制成纤维细胞增殖、巨噬细胞分化的AcSDKP异构体小肽,为该小肽进一步的体内研究及应用奠定了基础。 Objective: By D amino acids substitutions, AcSDKP isomers were synthesized for finding an angioten sinconverting enzyme(ACE) resistant peptide. The synthesized candidates were tested in vivo for its biological ac tivity. Methods: Degradation of AeSDKP isomers was measured by HPLC. Proliferation of L929 cells and cardiac fibroblasts were measured by MTT assay. Differentiation of bone marrow stem cells(BMSC) to macrophages was an alyzed by f/ow cytometry using F4/80 as a marker of macrophage maturation. Results: All the three AcSDKP iso mers can resist degradation by ACE. At the concentration of 108 tool/L, AcSDKP isomers inhibited L929 cells pro liferation, cardiac fibroblasts proliferation mediated by TGFI31, and differerntiation of BMSC to macrophages. Con clusion: Successfully obtained the AcSDKP isomers resisting degradation by ACE and having much biological activ ities.
出处 《生物技术通讯》 CAS 2012年第2期158-161,共4页 Letters in Biotechnology
关键词 AcSDKP小肽 异构体 抗纤维化 骨髓干细胞 心脏成纤维细胞 AcSDKP peptide isomers anti-fibrosis bone marrow stem cells cardiac fibroblasts
  • 相关文献

参考文献2

二级参考文献31

  • 1杨方,赵丹,马文东,罗玲,户万秘,王丽萍,朱曦玲,孙树勋.N-乙酰基-丝氨酰-天门冬酰-赖氨酰-脯氨酸对血小板洐生生长因子介导的NIH3T3细胞增殖的抑制调节作用[J].解剖学杂志,2005,28(6):618-620. 被引量:13
  • 2杨方,朱曦龄,王丽平,宋旭东,王瑞敏,李治国,罗玲,户万秘,马文东,裴鑫,张丽娟,李琪佳.抗纤维化短肽N-乙酰基-丝氨酰-天门冬酰-赖氨酰-脯氨酸对大鼠心脏成纤维细胞胶原合成与降解的调节作用[J].中华心血管病杂志,2006,34(9):843-846. 被引量:17
  • 3王丽平,朱曦龄,杨方,王瑞敏,马文东,罗玲,户万秘,李治国,李琪佳,裴新,张丽娟,王献华.N-乙酰基-丝氨酰-天门冬酰-赖氨酰-脯氨酸对大鼠心脏成纤维细胞胶原蛋白合成及表达的调节作用[J].解剖学杂志,2006,29(6):718-720. 被引量:8
  • 4Cavasin M A, Rhaleb N E, Yang X P, et al. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac - SDKP . Hypertension, 2004, 43(5) : 1140
  • 5Bogden A E, Moreau J P, Gamba - Vitalo C, et al. Goralatide (AcSD-KP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM -CSF. Int J Cancer, 1998, 76 : 38
  • 6Jackson J D, Ozerol E, Yan Y, et al. Activity of acetyl - Ser - Asp -Lys - Pro(AcSDKP) on human hematopoietic progenitor cells in short -term and long - term bone marrow cultures . J Hematother Stem Cell Res, 2000, 9 : 489
  • 7Watanabe T, Brown G S, Kelsey L S, et al. In vivo protective effects of tetrapeptide AcSDKP, with or without granulocytecolony - stimulation factor, on murine progenitor cells after sublethal irradiation . Exp Hematol, 1996, 24 : 713
  • 8Wierenge P K, Brenner M K, Konings AWT. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression . Bone Marrow Transplant, 1998,21 :73
  • 9Masse A, Ramirez L H, Bindoula G, et al. The tetrapeptide acetyl -N- Ser - Asp - Lys - Pro ( Goralatide ) protects from doxorubicin - induced toxicity: improvement in mice survival and protection of bone marrow stem cells and progenitors . Blood, 1998, 91(2) : 441
  • 10Suzuki A, Aizawa S, Araki S, et al. Enhanced engraftment of intravenously transplanted hematopoietic stem cells into bone marrow of irradiated mice treated with AcSDKP . Exp Hematol, 1998, 26(1 ) : 79

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部